High SVR rates in patients with and without cirrhosis treated in real life with Sofosbuvir/Velpatasvir (SOF/VEL) combination for 12 weeks without Ribavirin (RBV)

Saved in:
Bibliographic Details
Published inJournal of hepatology Vol. 68; pp. S273 - S274
Main Authors Mangia, A., Piazzolla, V., Losappio, R., Mazzola, M., Visaggi, E., Bacca, D., Sogari, F., Potenza, D., Santoro, R., Carraturo, I., Tagarielli, V., Lauletta, G., Giannelli, A., Gesualdo, A., Minerva, N.
Format Journal Article
LanguageEnglish
Published 01.04.2018
Online AccessGet full text

Cover

More Information
ISSN:0168-8278
DOI:10.1016/S0168-8278(18)30763-3